Medibank Pvt (ASX:MPL) ROE % Adjusted to Book Value: 4.60% (As of Dec. 2025)


ASX:MPL Medibank Pvt Ltd ASX:MPL
77 GF Score
Price A$4.99
GF Value A$4.38
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Medibank Pvt ROE % Adjusted to Book Value?

Medibank Pvt ASX:MPL +2.67% 77 ROE % Adjusted to Book Value is 4.60% as of Dec. 2025. GuruFocus rates ASX:MPL with a GF Score™ of 77/100 and a GF Value™ of A$4.38 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Medibank Pvt's ROE % for the quarter that ended in Dec. 2025 was 25.92%. Medibank Pvt's PB Ratio for the quarter that ended in Dec. 2025 was 5.64. Medibank Pvt's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 4.60%.


Medibank Pvt ROE % Adjusted to Book Value Related Terms


Medibank Pvt ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Medibank Pvt's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medibank Pvt ROE % Adjusted to Book Value Chart

Medibank Pvt Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.19 4.45 5.45 5.03 3.62

Medibank Pvt Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.42 2.87 6.63 2.28 4.60

ASX:MPL vs FNF, AXS, FAF: ROE % Adjusted to Book Value Comparison

For the Insurance - Specialty subindustry, Medibank Pvt's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medibank Pvt ROE % Adjusted to Book Value vs Insurance Industry

For the Insurance industry and Financial Services sector, Medibank Pvt's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Medibank Pvt's ROE % Adjusted to Book Value falls into.


ASX:MPL
77GF Score
Medibank Pvt Ltd ASX:MPL
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medibank Pvt ROE % Adjusted to Book Value Calculation

Medibank Pvt's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=21.58% / 5.96
=3.62%

Medibank Pvt's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=25.92% / 5.64
=4.60%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 4.60% mean?
Medibank Pvt (ASX:MPL) has a ROE % Adjusted to Book Value of 4.60% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Medibank Pvt and its competitors.
Is Medibank Pvt's ROE % Adjusted to Book Value too high?
Medibank Pvt's current ROE % Adjusted to Book Value is 4.60%. Overall, Medibank Pvt has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's ROE % Adjusted to Book Value compare to FNF and AXS?
Medibank Pvt's ROE % Adjusted to Book Value of 4.60% can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for an Insurance company?
A good ROE % Adjusted to Book Value depends on the Insurance industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Medibank Pvt and its competitors. Medibank Pvt's current ROE % Adjusted to Book Value is 4.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (ASX:MPL) is currently considered Modestly Overvalued. The stock's GF Value™ is A$4.38, compared to a current price of A$4.99 — trading 13.9% above its estimated fair value. The current ROE % Adjusted to Book Value is 4.60%. Medibank Pvt's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Medibank Pvt (ASX:MPL), the current ROE % Adjusted to Book Value is 4.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medibank Pvt (ASX:MPL) Overvalued in 2026?

Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued. The current stock price of A$4.99 is trading 13.9% above its estimated GF Value™ of A$4.38. GuruFocus considers Medibank Pvt to be Modestly Overvalued.

Key valuation signals for ASX:MPL:

  • ROE % Adjusted to Book Value: 4.60%
  • GF Value™: A$4.38 vs. price of A$4.99 (13.9% above fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the ASX:MPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medibank Pvt Business Description

Other Exchanges MDBPF:USAMDBKY:USA
Address 695 Collins Street, Medibank Melbourne Hub, Level 2, Docklands, Melbourne, VIC, AUS, 3008
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
77GF Score

Get the complete analysis for ASX:MPL

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$4.99
Price
A$4.38
GF Value